Literature DB >> 18938772

Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition.

Reidar Fossmark1, Constantin S Jianu, Tom C Martinsen, Gunnar Qvigstad, Unni Syversen, Helge L Waldum.   

Abstract

OBJECTIVE: Use of proton-pump inhibitors (PPIs) causes hypergastrinemia, and it is well known that gastrin has a trophic effect on the oxyntic mucosa. Some PPI users develop fundic gland polyps. The purpose of this study was to determine whether patients developing fundic gland polyps have a more pronounced gastric hypoacidity, hypergastrinemia or increased serum chromogranin A (CgA), which is an enterochromaffin-like (ECL) cell marker.
MATERIAL AND METHODS: Five PPI users who developed multiple fundic gland polyps during PPI use were included in the study. PPI users without fundic gland polyps (n = 6) as well as healthy individuals (n = 6) were used as controls. In PPI users, we measured 24-h gastric pH, serum gastrin and CgA during one day, with standardized meals, whereas only gastrin and CgA were measured in the healthy individuals. Helicobacter pylori status was determined.
RESULTS: Gastric pH, serum gastrin and CgA did not differ significantly between PPI users with and those without fundic gland polyps. All patients with fundic gland polyps were H. pylori negative, whereas 4 out of 6 PPI users without fundic gland polyps were H. pylori positive. Fasting CgA levels were elevated in all PPI users, and CgA more than doubled during the day in all groups.
CONCLUSIONS: Fundic gland polyps induced by PPIs are not related to the level of hypergastrinemia. Serum CgA is markedly affected by meals and should be measured in samples from fasting patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18938772     DOI: 10.1080/00365520701561959

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  15 in total

1.  A meal test improves the specificity of chromogranin A as a marker of neuroendocrine neoplasia.

Authors:  Constantin S Jianu; Reidar Fossmark; Unni Syversen; Øyvind Hauso; Helge L Waldum
Journal:  Tumour Biol       Date:  2010-05-18

2.  Large Fundic Gland Polyps in the Stomach.

Authors:  Sonia Varghese; Vu Le; Tauseef Ali
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-03

3.  Fundic gland polyps and association with proton pump inhibitor intake: a prospective study in 1,780 endoscopies.

Authors:  Adriana Zelter; José Luis Fernández; Claudio Bilder; Pablo Rodríguez; Andrés Wonaga; Fernanda Dorado; Miriam Galich; Luis Alberto Viola
Journal:  Dig Dis Sci       Date:  2010-12-03       Impact factor: 3.199

4.  Evaluation of chromogranin A determined by three different procedures in patients with benign diseases, neuroendocrine tumors and other malignancies.

Authors:  Rafael Molina; Elias Alvarez; Angeles Aniel-Quiroga; Maria Borque; Belen Candás; Antonio Leon; Rafael M Poyatos; Montserrat Gelabert
Journal:  Tumour Biol       Date:  2010-08-21

5.  Esomeprazole-induced hyperchromograninemia in the absence of concomitant hypergastrinemia.

Authors:  Giovanni Gori; Giacomo Spinelli; Claudio Spinelli; Marco Tuccori; Corrado Blandizzi; Mario Del Tacca
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-12       Impact factor: 46.802

Review 6.  Management of gastric polyps: an endoscopy-based approach.

Authors:  Yasser H Shaib; Massimo Rugge; David Y Graham; Robert M Genta
Journal:  Clin Gastroenterol Hepatol       Date:  2013-04-10       Impact factor: 11.382

7.  Chronic proton pump inhibitor therapy associated with increased development of fundic gland polyps.

Authors:  Mazer R Ally; Ganesh R Veerappan; Corinne L Maydonovitch; Timothy J Duncan; Joseph L Perry; Eric M Osgard; Roy K H Wong
Journal:  Dig Dis Sci       Date:  2009-10-15       Impact factor: 3.199

Review 8.  Management of gastric polyps: a pathology-based guide for gastroenterologists.

Authors:  Susanne W Carmack; Robert M Genta; David Y Graham; Gregory Y Lauwers
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-06       Impact factor: 46.802

Review 9.  Importance of gastrin in the pathogenesis and treatment of gastric tumors.

Authors:  Michael D Burkitt; Andrea Varro; D Mark Pritchard
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

Review 10.  Proton pump inhibitors and an emerging epidemic of gastric fundic gland polyposis.

Authors:  Hugh-James Freeman
Journal:  World J Gastroenterol       Date:  2008-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.